These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 18398801)
1. [Augmentation with atypical antipsychotics for the treatment of patients with a therapy-resistant depression: a review]. Selis MA; Peeters FP Tijdschr Psychiatr; 2008; 50(4):213-22. PubMed ID: 18398801 [TBL] [Abstract][Full Text] [Related]
2. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related]
3. Accelerating response to antidepressant treatment in depression: a review and clinical suggestions. Nakajima S; Suzuki T; Watanabe K; Kashima H; Uchida H Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):259-64. PubMed ID: 19969039 [TBL] [Abstract][Full Text] [Related]
4. Augmentation and combination strategies for depression. DeBattista C J Psychopharmacol; 2006 May; 20(3 Suppl):11-8. PubMed ID: 16644767 [TBL] [Abstract][Full Text] [Related]
5. Augmentation strategies for treatment-resistant depression: a literature review. Carvalho AF; Cavalcante JL; Castelo MS; Lima MC J Clin Pharm Ther; 2007 Oct; 32(5):415-28. PubMed ID: 17875106 [TBL] [Abstract][Full Text] [Related]
8. Potentiation strategies for treatment-resistant depression. Ros S; Agüera L; de la Gándara J; Rojo JE; de Pedro JM Acta Psychiatr Scand Suppl; 2005; (428):14-24, 36. PubMed ID: 16307616 [TBL] [Abstract][Full Text] [Related]
9. Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder. Papakostas GI Essent Psychopharmacol; 2005; 6(4):209-20. PubMed ID: 16041917 [TBL] [Abstract][Full Text] [Related]
11. To combine or not to combine? A literature review of antidepressant combination therapy. Dodd S; Horgan D; Malhi GS; Berk M J Affect Disord; 2005 Dec; 89(1-3):1-11. PubMed ID: 16169088 [TBL] [Abstract][Full Text] [Related]
12. [Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: a case report and review literature]. Buhagiar K; Cassar J Turk Psikiyatri Derg; 2007; 18(2):179-83. PubMed ID: 17566884 [TBL] [Abstract][Full Text] [Related]
13. Augmentation and combination strategies for complicated depression. Fava M J Clin Psychiatry; 2009 Nov; 70(11):e40. PubMed ID: 20031088 [TBL] [Abstract][Full Text] [Related]
14. The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Carvalho AF; Berk M; Hyphantis TN; McIntyre RS Psychother Psychosom; 2014; 83(2):70-88. PubMed ID: 24458008 [TBL] [Abstract][Full Text] [Related]
15. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731 [TBL] [Abstract][Full Text] [Related]
16. Treatment-resistant depression: critique of current approaches. Wijeratne C; Sachdev P Aust N Z J Psychiatry; 2008 Sep; 42(9):751-62. PubMed ID: 18696279 [TBL] [Abstract][Full Text] [Related]
17. What to do if an initial antidepressant fails? McIntyre RS; Müller A; Mancini DA; Silver ES Can Fam Physician; 2003 Apr; 49():449-57. PubMed ID: 12729241 [TBL] [Abstract][Full Text] [Related]
18. A novel approach to the psychopharmacologic treatment of insomnia in depression. Boyle A Med Hypotheses; 2004; 63(1):26-30. PubMed ID: 15193342 [TBL] [Abstract][Full Text] [Related]
20. Treatment of unipolar psychotic depression: the use of evidence in practice guidelines. Wijkstra J; Schubart CD; Nolen WA World J Biol Psychiatry; 2009; 10(4 Pt 2):409-15. PubMed ID: 17963187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]